4 Results Found

Advanced Search

Select all

Results per page

Select all

Review

4 Citations

3,778 Views

9 Pages

Ovarian Stem Cells for Women’s Infertility: State of the Art

Krzysztof Grettka,
Katarzyna Idzik,
Katarzyna Lewandowska,
Ksena Świętek,
Simone Palini and
Franco Silvestris

Biomedicines2024, 12(6), 1139;https://doi.org/10.3390/biomedicines12061139

21 May 2024

Today, women’s infertility is considered a social disease in females, occurring not only as an effect of POF (premature ovarian failure) but also as CTRI (cancer treatment-related infertility) in oncologic patients. Several procedures for FP (f...

Full Article

Review

7 Citations

4,131 Views

12 Pages

Ovarian Stem Cells (OSCs) from the Cryopreserved Ovarian Cortex: A Potential for Neo-Oogenesis in Women with Cancer-Treatment Related Infertility: A Case Report and a Review of Literature

Erica Silvestris,
Carla Minoia,
Attilio Guarini,
Giuseppina Opinto,
Antonio Negri,
Miriam Dellino,
Raffaele Tinelli,
Gennaro Cormio,
Angelo Virgilio Paradiso and
Giuseppe De Palma

Curr. Issues Mol. Biol.2022, 44(5), 2309-2320;https://doi.org/10.3390/cimb44050157

19 May 2022

Cancer treatment related infertility (CTRI) affects more than one third of young women undergoing anti-cancer protocols, inducing a premature exhaustion of the ovarian reserve. In addition to ovarian suppression by GnRHa, oocyte and cortex cryopreser...

Full Article

Brief Report

1,641 Views

9 Pages

Optimizing the Ovarian Tissue Cryopreservation in the ‘Oncofertility’ Institutional Program at an Italian National Cancer Institute

Erica Silvestris,
Carla Minoia,
Giuseppe De Palma,
Ondina Popescu,
Anna Altavilla,
Attilio Guarini,
Fabio Pavone,
Vera Loizzi,
Gennaro Cormio and
Raffaella Depalo

Healthcare2023, 11(20), 2727;https://doi.org/10.3390/healthcare11202727

13 October 2023

Background: The majority of female cancer patients undergoing anticancer treatments are at risk of experiencing ‘cancer treatment-related infertility’, which can result in permanent damage to their reproductive prospects. Among the fertil...

Full Article

Review

1 Citations

4,122 Views

14 Pages

Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview

Erica Silvestris,
Gennaro Cormio,
Vera Loizzi,
Giacomo Corrado,
Francesca Arezzo and
Easter Anna Petracca

Life2024, 14(5), 615;https://doi.org/10.3390/life14050615

10 May 2024

BRCA1 and BRCA2 mutations are responsible for a higher incidence of breast and ovarian cancer (from 55% up to 70% vs. 12% in the general population). If their functions have been widely investigated in the onset of these malignancies, still little is...

Full Article